top of page


Brazil and Innovation in Health: Potential and Challenges for Regional Leadership
In recent years, Brazil has intensified its efforts to strengthen the innovation environment in healthcare, with remarkable advances in...
Nov 7, 20244 min read


The Importance of Regulatory Agencies in Health Innovation and Pharmaceutical Regulation: FDA, EMA, and ANVISA in Perspective
Health innovation and the remarkable growth of the pharmaceutical sector—with a projected global revenue of USD 1.155 trillion in...
Nov 1, 20244 min read


Antimicrobial Resistance: Challenges and Opportunities for Health Investors
Antimicrobial resistance (AMR) is emerging as one of the greatest threats to global health and the economy. This phenomenon occurs when...
Oct 22, 20244 min read
bottom of page
